DIN 02241755 — SANDOZ TOBRAMYCIN 0.3 %
SANDOZ TOBRAMYCIN is a solution of Tobramycin marketed by SANDOZ CANADA INCORPORATED. The full Tobramycin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02241755
- Brand name
- SANDOZ TOBRAMYCIN
- Active ingredient
- Tobramycin
- Strength
- 0.3 %
- Dosage form
- SOLUTION
- Route
- OPHTHALMIC
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- Aminoglycoside antibiotic
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Tobramycin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02245698 | APO-TOBRAMYCIN | 0.3 % | SOLUTION | APOTEX INC | DORMANT |
| 02389622 | TEVA-TOBRAMYCIN | 60 MG | SOLUTION | TEVA CANADA LIMITED | MARKETED |
| 02239630 | TOBI | 300 MG | SOLUTION | BGP PHARMA ULC | MARKETED |
| 02365154 | TOBI PODHALER | 28 MG | CAPSULE | BGP PHARMA ULC | MARKETED |
| 00533688 | TOBRAMYCIN FOR INJECTION | 1.2 G | POWDER FOR SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02285150 | TOBRAMYCIN FOR INJECTION USP | 1.2 G | POWDER FOR SOLUTION | STERIMAX INC | DORMANT |
| 02241209 | TOBRAMYCIN INJECTION USP | 10 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02241210 | TOBRAMYCIN INJECTION USP | 40 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02502372 | TOBRAMYCIN INJECTION USP | 40 MG | SOLUTION | STERIMAX INC | MARKETED |
| 02533103 | TOBRAMYCIN INJECTION USP | 40 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02230640 | TOBRAMYCIN INJECTION, USP | 40 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 00513962 | TOBREX | 0.3 % | SOLUTION | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 00614254 | TOBREX | 0.3 % | OINTMENT | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |